Skip to main navigationSkip to News Headlines
NJ Division of Consumer Affairs
Global Navigation
Division of Consumer Affairs
The State of New Jersey Office of The Attorney General (Dept. of Law & Public Safety) The State of New Jersey NJ Home Services A to Z Departments/Agencies OAG Frequently Asked Questions
OAG Home
OAG Contact
Division of Consumer Affairs Alerts and Recalls
Division of Consumer Affairs Alerts and Recalls
Office of the Attorney General Homepage Division of Consumer Affairs, Director
Division of Consumer Affairs, Director
Division of Alcoholic Beverage Control
Division of Consumer Affairs
Division of Consumer Affairs Highlights
Division of Consumer Affairs Topics in a A-Z List Format
Office of Consumer Protection (OCP)
New Jersey Bureau of Securities
Office of Weights and Measures
Legalized Games of Chance Control Commission
Alternative Dispute Resolution
Professions and Occupations List
Contact the Division of Consumer Affairs
Division of Consumer Affairs in Spanish
Division of Criminal Justice
Division on Civil Rights
Division of Gaming Enforcement
Division of Highway Traffic Safety
Division of Law
Juvenile Justice Commission
NJ Racing Commission
State Athletic Control Board
Division of NJ State Police
Victims of Crime Compensation Office
 
OPRA - Open Public Records Act
Download Free PDF Reader

Jeffrey S. Chiesa,
Attorney General

Division of Consumer Affairs
Eric T. Kanefsky, Acting Director

 

 

For Immediate Release:
March 22, 2013
For Further Information Contact:
Jeff Lamm, 973-504-6327
Neal Buccino, 973-504-6327

 

State Board of Pharmacy, Med Prep Enter Voluntary Agreement, Extending Halt to Pharmacy's Operations Following Recall

View Second Voluntary Consent Order

View Voluntary Consent Order

NEWARK – The New Jersey State Board of Pharmacy today announced a Second Voluntary Interim Consent Order with Med Prep Consulting Inc., a compounding pharmacy in Tinton Falls, to further extend the temporary cessation of all of Med Prep's pharmacy activities pending further examination into the cause of contamination found in magnesium sulfate products compounded by the company.

The Board of Pharmacy on Friday, March 15, entered into an initial Interim Voluntary Consent Order with Med Prep, under which the business agreed to temporarily halt all pharmacy operations until at least today. (View 3/15/13 Press Release)

Under the terms of today's agreement, Med Prep has agreed to remain closed until at least April 5, while the State Division of Consumer Affairs and its Enforcement Bureau, in partnership with the State Department of Health, State Board of Pharmacy, U.S. Food and Drug Administration, and U.S. Centers for Disease Control and Prevention, continue to investigate the root cause of the contamination found in the Med Prep products. 

"This agreement between the Board of Pharmacy and Med Prep ensures the company will remain closed, while we continue to investigate the root cause of the contamination that was discovered in certain Med Prep products last week," Attorney General Jeffrey S. Chiesa said.  "The State Division of Consumer Affairs and its Enforcement Bureau, on behalf of the State Board of Pharmacy, continue to investigate this matter in partnership with the State Department of Health, U.S. Food and Drug Administration, and Centers for Disease Control and Prevention."

"There are no reported illnesses associated with this recall at this time," said Health Commissioner Mary E. O'Dowd. "The Department is working closely on this ongoing investigation with affected health care facilities in New Jersey and with the CDC, the FDA, Connecticut, Pennsylvania and the state Board of Pharmacy."

Neither today's Consent Order nor the initial Consent Order is a disciplinary action, and does not represent an admission of wrongdoing by Med Prep.

This action results from the identification of visible particulate contaminants, by the staff of a Connecticut hospital, in bags of magnesium sulfate intravenous solution that had been compounded by Med Prep and dispensed to the hospital. As of this date, no injuries or illnesses have been reported.

Med Prep and the FDA on March 16 publicly announced a voluntary recall of bags of magnesium sulfate intravenous solution compounded by Med Prep.  The recall notice can be found at http://www.fda.gov/Safety/Recalls/ucm344189.htm.  On March 17, Med Prep and the FDA publicly announced an expanded recall of all lots of all Med Prep compounded products.  A revised version of that recall notice, issued on March 20, can be found at http://www.fda.gov/Safety/Recalls/ucm344787.htm.

Deputy Attorneys General Kim Ringler and Jodi Krugman, of the New Jersey Division of Law, are representing the State in this matter.

Follow the Division of Consumer Affairs on Facebook, and check our online calendar of upcoming Consumer Outreach events.

####

   
Contact Us | Privacy Notice | Legal Statement | Accessibility Statement
NJ Home Logo
Divisional: DCA Home | Complaint Forms | Proposals | Adoptions | Contact DCA
Departmental: OAG Home | Contact OAG | About OAG | OAG News | OAG FAQs
Statewide: NJ Home | Services A to Z | Departments/Agencies | FAQs
Copyright State of New Jersey
This page is maintained by DCA. Comments/Questions: email

Page last modified: